Friday, March 1, 2024

Will Colon Cancer Show Up In Blood Work

Why Is Bowel Cancer Screening Important

Is there a blood test for colorectal cancer? – Dr. Brian Lacy

A bowel cancer screening test can show early signs of bowel cancer. It can show up signs of cancer even before you have symptoms. Screening tests are different from other tests done when there are signs of sickness. Screening can find a cancer at an early stage. Bowel cancer can be cured if its found early.

Bowel cancer can grow inside your bowel for many years. There are often no signs until the cancer gets bigger. In Australia, about 100 people die each week from bowel cancer. This number could be much smaller if people had screening tests to find cancer early.

Stages Of Bowel Cancer

After all tests have been completed, it’s usually possible to determine the stage of your cancer.

There are 2 ways that bowel cancer can be staged.

The first is known as the TNM staging system:

  • T indicates the size of the tumour
  • N indicates whether the cancer has spread to nearby lymph nodes
  • M indicates whether the cancer has spread to other parts of the body

Bowel cancer is also staged numerically. The 4 main stages are:

  • stage 1 the cancer is still contained within the lining of the bowel or rectum
  • stage 2 the cancer has spread beyond the layer of muscle surrounding the bowel and may have entered the surface covering the bowel or nearby organs
  • stage 3 the cancer has spread into nearby lymph nodes
  • stage 4 the cancer has spread beyond the bowel into another part of the body, such as the liver

Cancer Research UK has more information about bowel cancer stages.

Bright Red Blood: A Sign Of Colon Cancer

Blood in the stool is commonly a sign of hemorrhoids, not colon cancer. As the stool passes along, the swollen tissue may obstruct the stool, causing the hemorrhoid to rupture and bleed. The blood is usually bright red in color and watery in consistency.

On the other hand, bleeding from colon cancer is typically described as darker in appearance. Stool ranging from maroon to tar-like can be a sign of colon abnormalities. This is because the blood is produced higher up in the colon and is less fresh than one from a hemorrhoid rupture.

Again, its impossible to accurately diagnose colon cancer from the color of the stool alone. We recommend a proper examination to really understand your state of health.

Recommended Reading: Most Common Blood Pressure Medication

Colorectal Cancer Screening: Are Stool And Blood Based Tests Good Enough

Chung-Wah Wu, Joseph Jao-Yiu Sung

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China

Corresponding to:

Abstract

Colorectal cancer is the third commonest cancer worldwide. As many CRC patients were identified at advanced stages, screening asymptomatic individuals has substantial clinical benefit. Most CRC arises through recognizable early stage. With the improved understanding of the biology of CRC and precancerous lesion, testing molecular aberrations in stool and blood promises novel screening approaches that are noninvasive, sensitive, and more affordable compared with traditional structural examinations.

Key words: Colorectal cancer screening biomarkers stool

Submitted Oct 13, 2012. Accepted for publication Nov 19, 2012.

doi: 10.3978/j.issn.2304-3865.2012.11.07

Does Ovarian Cancer Show Up On Blood Work

Cancer screening by simple bowel cancer
  • Related Resources – Does Ovarian Cancer Show Up on Blood Work?
  • A person with ovarian cancer may have high levels of a substance called the CA-125 in the blood. CA-125 antigen is known by several other names, such as ovarian cancer antigen and CA-125 tumor marker. It is a protein present on the surface of most ovarian cells. Thus, significantly high levels of CA-125 may be seen in the blood of ovarian cancer patients. Since all ovarian cancer types do not possess this protein, not all women with ovarian cancer will have high blood levels of CA-125.

    CA-125 may be elevated in several noncancerous conditions, such as

    Hence, elevated CA-125 levels do not definitely mean that the person has ovarian cancer. The CA-125 blood test is not recommended for screening women with low to moderate ovarian cancer risk. The test, nonetheless, does have several important uses, such as

    • Monitoring the response to treatment for ovarian cancer. Declining CA-125 levels generally mean that the tumor is responding to treatment.
    • Finding out whether the tumor has returned after successful treatment.
    • Screening women with a high risk for ovarian cancer, such as those who have
    • Certain abnormal genes: BRCA1 and BRCA2
    • The gene associated with Lynch syndrome or Peutz-Jeghers syndrome
    • A history of cancer of the breast, colon or uterus
    • A family history of ovarian cancer, breast cancer or colorectal cancer

    Read Also: Blood At The End Of Urination

    Can Colon Cancer Be Detected In Ultrasound

    Although not suitable as a first choice screening procedure for colorectal cancer, routine abdominal ultrasound can detect even non-suspected colonic tumors, especially in the ascending colon. Since the specificity of ultrasound is probably low, diagnosis must be confirmed by X-ray and/or endoscopy.

    Crc Screening: Blood Test Accuracy Compared To Colonoscopy

    Damian McNamara

    May 21, 2022

    The first prospective study to evaluate the accuracy of a blood test for people being screened for colorectal cancer revealed a high sensitivity and specificity.

    At 90% specificity, the blood assay was 100% sensitive for detecting CRC. At 95% specificity, sensitivity was 88%.

    The blood assay detects circulating tumor DNA from cancer in the bloodstream, which is then analyzed for multiple factors, including cancer genetics and methylation.

    Lead author Paloma Peinado, MD, a medical oncologist at HM Hospitales in Madrid, Spain, and colleagues, called the results similar to those seen with noninvasive, stool-based testing, noting that the “sensitivity and specificity of the blood-based test reach clinically significant thresholds.”

    “The reported performance, combined with a more acceptable mode of testing, suggests that this blood-based test may be a viable CRC screening option,” they added.

    Our study is the first prospective real-world population study testing this assay, Peinado said. It is promising to see that the performance in the screened cohort is consistent with previously reported data in case-cohort studies.

    The study was presented May 21 at Digestive Disease Week 2022, held virtually and in San Diego, California.

    Peinado and colleagues studied 557 people who agreed to have blood drawn at the time of their colonoscopy. They enrolled participants at four hospitals in Spain.

    Don’t Miss: Apps For Blood Pressure Monitoring

    Removing Polyps At Colonoscopy

    If a pre-cancerous lesion, such as an adenomatous polyp of the colon or rectum, is found it may be removed during the colonoscopy.

    Healthy tissue around the polyp will also be removed. This is called a local resection. It aims to make sure no abnormal cells are left behind.

    If your test results show there are any cancer cells within the polyp, you may need another operation to remove any cancerous cells left behind

    You will also need more tests to find out the type of bowel cancer and if it has spread to other parts of your body.

    These tests include:

    CT scan

    A CT scan uses x-rays from different angles to make a 3D picture of inside your body and show smaller cancers than an x-ray.

    An MRI uses magnets and radio waves to make a detailed picture of the inside of your body.

    PET/CT scan

    The scan begins by injecting a radioactive dye into your arm. The dye will attach to the cancer cells. You will have two types of scans that will find which areas in the body where the cancer may be.

    Can An Ultrasound Detect Liver Cancer

    Blood tests help detect colon cancer

    Imaging scans. Tests that create pictures of the inside of the body are known as imaging scans. Ultrasound is commonly used to look for primary liver cancer and also to monitor people with cirrhosis. Ultrasound alone cannot confirm a diagnosis of liver cancer, so you will also have one or more other scans.

    Also Check: Can Stress Increase Blood Pressure

    Your Blood Can Tell If You Have Colon Cancer

    Colon cancer is the third most common cancer in the United States. The American Cancer Society predicts the cancer will cause 51,020 deaths in 2019 alone. However, the overall death rate is starting to drop, thanks to more advanced treatments developed over the last decade.

    Detecting colon cancer with blood alone may have been an impossibility just a few years ago, but new developments are starting to suggest otherwise. Can blood tests diagnose colon cancer? A new discovery suggests that it may be possible by identifying circulating tumor cells in the blood.

    Overall, colon cancer is still a difficult disease to identify, let alone treat. Multiple testing is often required to reach a conclusive diagnosis. But with a proactive attitude towards screening and testing, there are ways to significantly reduce the risk of developing colon cancer.

    Is Blood Work Normal With Colon Cancer

    Ask U.S. doctors your own question and get educational, text answers â it’s anonymous and free!

    Ask U.S. doctors your own question and get educational, text answers â it’s anonymous and free!

    HealthTap doctors are based in the U.S., board certified, and available by text or video.

    Also Check: Normal Blood Sugar For Pregnancy

    Who Is At Risk For Colorectal Cancer

    In the United States, colorectal cancer is most common in adults aged 65 to 74. Rates of new colorectal cancer cases are decreasing among adults aged 50 years or older due to an increase in screening and to changes in some risk factors . However, incidence is increasing among younger adults for reasons that are not known.

    An analysis of US population-based cancer registry data from NCIs Surveillance, Epidemiology, and End Results program for 2000 to 2014 shows that, each year over this period, the incidence of colorectal cancer increased 2.7% among 20- to 39-year-olds and 1.7% among 40- to 49-year-olds while decreasing 0.5% among 50- to 59-year-olds, 3.3% among 60- to 69-year-olds, and 3.8% among 70- to 79-year-olds .

    Although the percentage increases were higher in the younger age groups than the older age groups, fewer colorectal cancers were still diagnosed in younger people than older people .

    The major risk factors for colorectal cancer are older age and having certain inherited conditions , but several other factors have also been associated with increased risk, including a family history of the disease, excessive alcohol use, obesity, being physically inactive, cigarette smoking, and, possibly, diet.

    In addition, people with a history of inflammatory bowel disease have a higher risk of colorectal cancer than people without such conditions.

    Blood Messenger Rna And Microrna

    Human Microvascular Endothelial Cells Lung Hmvec L

    Few studies had exploited blood based mRNA as CRC biomarkers. Identified by oligonucleotide microarray analysis on colorectal tissues, KIAA1199 was described as a CRC biomarker, however its function remains not clearly understood . Serum KIAA1199 mRNA level demonstrated a sensitivity of 74% for CRC and adenoma, and a specificity of 66%, based on a cohort of 20 CRC, 20 adenoma and 20 normal subjects. More studies had focused on plasma miRNAs, largely because they remained very stable in plasma and could be robustly quantified . Plasma based miRNA was first demonstrated to be useful as CRC biomarkers by Ng et al. . They reported plasma miR-92a, a candidate identified by miRNA array profiling, had a sensitivity of 89% and a specificity of 70% in discriminating CRC from control subjects. Notably, plasma miR-92a level dropped significantly upon the removal of tumor, showing the marker was likely to be derived from the colorectal lesions. Since then, more miRNA candidates were reported, including miR-29a , miR-221 , miR-21 , U2 small nuclear RNA , miR-601 and miR-760 . Among them, RNU2-1, a marker for both CRC and pancreatic ductal adenocarcinoma , was found to have a sensitivity of 97.7% in detecting CRC and/or PDAC, at a specificity of 90.6%. But this has not yet been tested in another independent study.

    Read Also: High Blood Pressure Medical Term

    Preparing For A Fecal Occult Blood Test

    Although performed at home, some preparation is necessary for successful testing. Certain medications and foods can affect the results of the FOBT. As such, its important to follow common guidelines to ensure accurate results:

    • Consult your doctor regarding the special diet. Certain foods affect test results, which is why its important to know foods that are permissible to eat. Raw fruits and vegetables are generally a no-go. Red meat such as beef and pork are usually banned by doctors for up to 72 hours before the test because blood in the meat may cause a false positive result
    • Citric foods rich in Vitamin C may also alter the test. Stay away from foods and beverages with high vitamin C content
    • Certain medication may interfere with the exam. Your doctor will put certain medicines on hold up to 72 hours before the exam

    Blood Test Could Help Decide Which Colon Cancer Patients Need Chemotherapy

    A blood test under study may soon be able to help many patients with colon cancer decide whether they need chemotherapy after surgery, or if they can safely skip it.

    The results, which oncologists described as promising, were published in the journal Nature Medicine.

    Currently, many patients with surgically removable colon cancer are automatically given additional chemotherapy, but doctors can’t perfectly predict who will or will not benefit from this. Although the blood test may need to be studied further before it becomes part of standard medical care, oncologists see it as a promising tool that could help many patients safely skip chemotherapy — and its harsh side effects.

    “Potentially, worldwide, we’re talking about millions of people,” said Dr. Alok Khorana, director of the gastrointestinal malignancies program at the Cleveland Clinic, who was not involved with the study. “Colorectal cancer is one of the most common cancers in the country, affecting both men and women. Worldwide, it’s also very common and is rising in many countries where in the past, it was not that common.”

    Still, experts said, more research is needed before this test becomes a standard part of medical care.

    Don’t Miss: Does Diabetes Cause Low Blood Pressure

    What Are The Bowel Cancer Symptoms I Need To Look Out For

    Not all bowel cancers show symptoms. Experiencing symptoms does not necessarily mean you have bowel cancer. However, you should see your doctor if you notice:

    • bleeding from the back passage or any sign of blood after a bowel motion
    • a change in usual bowel habit, such as straining to go to the toilet or loose motions
    • abdominal pain or bloating
    • weight loss for no obvious reason, or loss of appetite
    • symptoms of anaemia, including unexplained tiredness, weakness or breathlessness.

    Can A Blood Test Detect Colon Cancer

    Spectrum Health Blood Test Screens for Colon Cancer

    Colon cancer cant be directly identified from your blood alone. Blood tests are usually supplementary tests performed by doctors to understand your overall health. Trace elements from carcinogens can appear in your blood test results, which inform doctors about abnormalities in your body.

    The common blood tests performed to detect colon cancer are:

    Fecal occult blood test . Occult blood is blood that is invisible to the naked eye. A sample of your stool is studied to check for problems in the digestive tract. Positive results dont necessarily mean colon cancer benign tumors, ulcers, and other conditions concerning the digestive tract may also cause results to come back positive.

    Carcinoembryonic antigen . The CEA is less of a test and more of a trace element. Cancerous cells sometimes produce this chemical in the blood. Doctors usually track the level of CEA in a patients body over a long period of time. This helps them understand how colon cancer is progressing in the body. Treatment efficacy is also based on long-term CEA levels.

    Recommended Reading: Reasons Why You Can T Donate Blood

    Is The Epi Procolon Test Covered By Insurance

    Whether the Epi proColon test is covered depends on the type of insurance you have. Its a good rule of thumb to check in with your insurance provider if youre ever unsure about whether a particular test is covered.

    For example, Medicare states that theyll cover an approved blood-based biomarker screening for CRC once every 3 years.

    However, the Centers for Medicare and Medicaid Services , which administers Medicare, has said that the Epi proColon test doesnt meet its sensitivity and specificity criteria for coverage.

    Other Lab Tests For Colorectal Cancer

    In addition to stool tests, other lab tests may be recommended to help doctors diagnose and stage colorectal cancer and/or follow the progress of your treatment.

    These include:

    Genomic tumor assessment: Genomic testing is used to analyze a tumor on a molecular level to identify DNA alterations that may be driving the cancers growth. By identifying the mutations in a cancer cell’s genome, doctors may better understand what caused the tumor and tailor treatment based on these findings. Learn more about genomic tumor assessment.

    CBC test: Complete blood count tests may be used to measure different types of cells in the blood. A CBC test may be particularly helpful in determining whether you have too few red blood cells, which causes anemia. This may be a concern for colorectal cancer patients, because it may indicate that they have a tumor thats been bleeding for some time.

    Liver function tests: These blood tests may be performed to assess the function of the liver and determine whether colorectal cancer has spread to that organ.

    Tumor marker tests: This blood test may be used in addition to other tests for patients who are being treated for colorectal cancer. Tumor marker tests are used to check for two substances in the blood that colorectal cancer may produce: carcinoembryonic antigen and CA 19-9. The tests may help determine an appropriate course of treatment and, sometimes, whether the disease is likely to recur.

    Read Also: Blood Testing For Food Allergies

    Latest news
    Related news